Allelic expression of phase II metabolizing enzymes and relationship to irinotecan toxicity [0.03%]
二期代谢酶的等位基因表达及其与伊立替康毒性的关系
Marsha Tadje
Marsha Tadje
Many drugs are associated with variable response rates and, of the 1,200 drugs approved for use in the United States, about 15% are associated with adverse drug responses (Jorde, Carey, & Bamshad, 2010c). Often, variable response and risk f...
Care of the open abdomen after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies [0.03%]
腹膜表面恶性肿瘤细胞减灭术及术后腹腔热灌注化疗的开放性腹腔护理
Deena Damsky Dell,Jeanne Held-Warmkessel,Pamela Jakubek et al.
Deena Damsky Dell et al.
A patient with a mucinous appendiceal cancer presents to the surgeon complaining of abdominal discomfort and nausea. Having undergone a prior right hemicolectomy, the patient has been disease free and on surveillance with clinical and carci...
Implementing evidence-based practice using an interprofessional team approach [0.03%]
基于多学科团队的方法实施循证实践
Susan Bohnenkamp,Nicole Pelton,Cindy J Rishel et al.
Susan Bohnenkamp et al.
Translational research has been defined as "bench-to-bedside" research or "laboratory-to-clinical" research. Benefits to this type of research are that it fast tracks biomedical advances to improve the quality of care and life for patients ...
Measurements in quantitative research: how to select and report on research instruments [0.03%]
定量研究中的测量：如何选择和报告调查工具
Teresa L Hagan
Teresa L Hagan
Measures exist to numerically represent degrees of attributes. Quantitative research is based on measurement and is conducted in a systematic, controlled manner. These measures enable researchers to perform statistical tests, analyze differ...
Healthcare providers' perspectives of the supportive care needs of men with advanced prostate cancer [0.03%]
晚期前列腺癌患者的照护需求：医务人员的视角
Nancy Carter,Patricia A Miller,Brittany R Murphy et al.
Nancy Carter et al.
Purpose/objectives: To examine healthcare providers' (HCPs') perceptions of the supportive care needs of men with advanced prostate cancer (APC). Research...
Older adults newly diagnosed with symptomatic myeloma and treatment decision making [0.03%]
老年初诊有症状单克隆免疫球蛋白病患者的治疗决策过程
Joseph D Tariman,Ardith Doorenbos,Karen G Schepp et al.
Joseph D Tariman et al.
Purpose/objectives: To describe the preferences for participation in decision making of older adult patients newly diagnosed with symptomatic myeloma and to explore the association between sociodemographic variables and d...
Multicenter Study
Oncology nursing forum. 2014 Jul 1;41(4):411-9. DOI:10.1188/14.ONF.411-419 2014
Symptoms, coping, and quality of life in pediatric brain tumor survivors: a qualitative study [0.03%]
儿童脑瘤幸存者的症状、应对机制和生活质量：定性研究
Gail Macartney,Dawn Stacey,Margaret B Harrison et al.
Gail Macartney et al.
Purpose/objectives: To explore the symptom experience, coping strategies, and children's descriptions of their quality of life (QOL) after treatment for a brain tumor. ...
Oncology nurses and the experience of participation in an evidence-based practice project [0.03%]
肿瘤科护士参与实证护理项目的情况及体会
Mary Fridman,Keville Frederickson
Mary Fridman
Purpose/objectives: To illuminate the experiences of oncology nurses who participated in an evidence-based practice (EBP) project in an institution with an EBP organizational structure. ...
Exploring palliative care provision for recipients of allogeneic hematopoietic stem cell transplantation who relapsed [0.03%]
异基因造血干细胞移植后复发患者的姑息治疗研究
Elise B Button,Nicole C Gavin,Samantha J Keogh
Elise B Button
Purpose/objectives: To quantify the characteristics of patients who die in the hospital from relapse after allogeneic hematopoietic stem cell transplantation (alloHSCT), explore palliative care integration and end-of-life...
Psychosocial trajectories of men monitoring prostate-specific antigen levels following surgery for prostate cancer [0.03%]
前列腺癌手术后监测前列腺特异性抗原水平的男性心理社会轨迹
Donald E Bailey Jr,Meredith Wallace Kazer,Thomas J Polascik et al.
Donald E Bailey Jr et al.
Purpose/objectives: To describe the psychosocial trajectories of men treated surgically for prostate cancer after monitoring their prostate-specific antigen (PSA) levels until 24 months post-treatment. ...